Preparation of bicalutamide polymorphs by mixed solvents induced precipitation

JI Hua;LE Yuan;SHEN ZhiGang;CHEN JianFeng*

Journal of Beijing University of Chemical Technology ›› 2008, Vol. 35 ›› Issue (4) : 14-17.

PDF(1656 KB)
Welcome to Journal of Beijing University of Chemical Technology, Today is July 26, 2025
Email Alert  RSS
PDF(1656 KB)
Journal of Beijing University of Chemical Technology ›› 2008, Vol. 35 ›› Issue (4) : 14-17.
化学与化学工程

Preparation of bicalutamide polymorphs by mixed solvents induced precipitation

  • JI Hua;LE Yuan;SHEN ZhiGang;CHEN JianFeng*
Author information +
History +

Abstract

The polymorphism of bicalutamide and the factors affecting its crystal formation have been studied. The standard forms of bicalutamide were prepared by evaporat ion and meltingcooling processes. Two crystalline forms of bicalutamide were o btained by antisolvent precipitation and their structures were determined by c omparing their X-ray powder diffraction patterns with those of the standard for ms. A range of mixed solvents were screened in order to determine the optimum sy stem. It was shown that changing the volume ratio of two solvents can induce cry stallization of different polymorphs. 

Cite this article

Download Citations
JI Hua;LE Yuan;SHEN ZhiGang;CHEN JianFeng*. Preparation of bicalutamide polymorphs by mixed solvents induced precipitation[J]. Journal of Beijing University of Chemical Technology, 2008, 35(4): 14-17

References

[1]Yu Z Q, Tan R H B, Chow P S. Effect of operating conditions o n agglomeration and habit of paracetamol crystals in antisolvent crystallizati on[J]. Journal of Crystal Growth, 2005, 279(3-4): 477-488. 
[2]Vippagunta S R, Brittain H G, Grant D J W. Crystalline solids[J]. A dvanced Drug Delivery Reviews, 2001, 48:3-26. 
[3]Wirth M P, Hakenberg O W, Froehner M. Antiandrogens in the treatment of prostate cancer[J]. European Urology, 2006, 51(2): 306-314. 
[4]Vega D R, Polla G, Martinez A, et al. Conformational polymorphism in bicalutamide[J]. International Journal of Pharmaceuticals, 2006, 328(2):112-11 8. 
[5]Westheim R J H, Nijmegen. Bicalutamide forms: US, 0063782 A1[P], 20 040401. 
[6]Jenkins S, Liversidge G. Nanoparticulate bicalutamide formulations: U S, 0159767 A1[P], 20060620.
PDF(1656 KB)

4652

Accesses

0

Citation

Detail

Sections
Recommended

/